Literature DB >> 7679822

Two-year experience with FK 506 in pediatric patients.

A G Tzakis1, J Reyes, S Todo, B Nour, R Shapiro, M Jordan, J McCauley, J Armitage, J J Fung, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7679822      PMCID： PMC2991121     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

1.  FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.

Authors:  A G Tzakis; K Abu-Elmagd; J J Fung; E J Bloom; B Nour; F Greif; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.

Authors:  J Reyes; A Tzakis; M Green; B Nour; M Nalesnik; D Van Thiel; M Martin; M K Breinig; J J Fung; M Cooper
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome.

Authors:  J McCauley; R Shapiro; V Scantlebury; N Gilboa; M Jordan; C Jensen; A Naik; A Tzakis; D Ellis; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation.

Authors:  J M Armitage; F J Fricker; P Del Nido; L Cipriani; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  FK 506 versus cyclosporine in pediatric liver transplantation.

Authors:  A G Tzakis; J Reyes; S Todo; M Green; T Ohya; A Jain; K Abu-Elmagd; M Alessiani; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  FK 506 conversion of renal allografts failing cyclosporine immunosuppression.

Authors:  M L Jordan; R Shapiro; C W Jensen; V Scantlebury; J Fung; A Tzakis; J McCauley; A Jain; J Demetrius; P Randhawa
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

7.  Pediatric renal transplantation under FK 506 immunosuppression.

Authors:  C W Jensen; M L Jordan; F X Schneck; R Shapiro; A Tzakis; T R Hakala; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

8.  FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.

Authors:  P B Carroll; H Rilo; J Reyes; R Alejandro; Y Zeng; C Ricordi; A Tzakis; R Shapiro; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

9.  Use of FK 506 in pediatric patients.

Authors:  A G Tzakis; J J Fung; S Todo; J Reyes; M Green; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

10.  Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.

Authors:  A G Tzakis; C Ricordi; R Alejandro; Y Zeng; J J Fung; S Todo; A J Demetris; D H Mintz; T E Starzl
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321
  10 in total
  10 in total

Review 1.  Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients.

Authors:  G V Mazariegos; A A Salzedas; A Jain; J Reyes
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.

Authors:  W J Sam; M Aw; S H Quak; S M Lim; B G Charles; S Y Chan; P C Ho
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

Review 3.  Immunosuppressive drugs in paediatric liver transplantation.

Authors:  I D van Mourik; D A Kelly
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.

Authors:  A Jain; G Mazariegos; R Kashyap; M Green; C Gronsky; T E Starzl; J Fung; J Reyes
Journal:  Transplantation       Date:  2000-08-27       Impact factor: 4.939

Review 5.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.

Authors:  P E Wallemacq; V Furlan; A Möller; A Schäfer; P Stadler; I Firdaous; A M Taburet; R Reding; S Clement De Clety; J De Ville De Goyet; E Sokal; L Lykavieris; V Van Leeuw; O Bernard; J B Otte; N A Undre
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

Review 7.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 8.  Clinical use of tacrolimus (FK-506) in infants and children with renal transplants.

Authors:  D Ellis
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

9.  Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients.

Authors:  S Furth; A Neu; P Colombani; L Plotnick; M E Turner; B Fivush
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

10.  Long-term Follow-up of a Randomized Trial of Tacrolimus or Cyclosporine A Microemulsion in Children Post Liver Transplantation.

Authors:  Carla Lloyd; Adam Arshad; Paloma Jara; Martin Burdelski; Bruno Gridelli; J Manzanares; Michele Colledan; Emmanuel Jacquemin; Raymond Reding; Ulrich Baumann; Deirdre Kelly
Journal:  Transplant Direct       Date:  2021-09-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.